Professional Medical Expertise Company (9574) Fair Value & Analysis
Healthcare · SA · Market cap 291M SAR
Fair value as of: Aug 1, 2026
From 17 valuation models · updated today
Share price −0.9% over the past month.
What matters now
- The price is below even our cautious bear case (104.78 SAR). The market is more pessimistic than our downside scenario.
- The model range is unusually wide (104.78 SAR to 281.86 SAR). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (50/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (12 months)
12‑month range 76.15 SAR – 102.90 SAR · fair‑value band 104.78 SAR – 281.86 SAR · the 83.25 SAR price screens below the 218.52 SAR fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Professional Medical Expertise Company (9574) currently trades at 83.25 SAR, while our model-based Fair Value estimate is 218.52 SAR, implying the stock looks roughly 162.5% undervalued today. We read business quality at 50/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Professional Medical Expertise Company generated revenue of 419M SAR at a net margin of 10.0%. Revenue grew 38.0% year over year. It earns a return on equity of 31.7%. Net debt stands at 122M SAR. Fundamentals as of Aug 1, 2026
Our scenario range runs from 104.78 SAR (bear case) to 281.86 SAR (bull case); at 83.25 SAR, the current price sits below that range. The share trades about 22% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -29% fair-value upside, at 162%, 9574 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Professional Medical Expertise Company engages in the retail sale of medical equipment, tools, supplies, and medical devices in the Kingdom of Saudi Arabia and the United Arab Emirates.
Full company description
Professional Medical Expertise Company engages in the retail sale of medical equipment, tools, supplies, and medical devices in the Kingdom of Saudi Arabia and the United Arab Emirates. It offers products related to spine, sports medicine, pediatric orthopedic, general surgery, infection prevention, oncology, urology, minimal invasive surgery, cardiovascular, bariatric surgery, women's health, critical care, and diabetes, as well as dental care unit. The company is also involved in medical devices and supplies; sales agents for pharmaceuticals; sale of orthopedic devices, medical equipment, and herbal medical preparations; devices; storage of medical devices and products, cosmetics, and pharmaceutical preparations; and manufacturers medical devices and products, and integrated administrative office services. The company was formerly known as Socrates Specialized Trading Company and changed its name to Professional Medical Expertise Company in July 2012. Professional Medical Expertise Company was founded in 2010 and is headquartered in Jeddah, the Kingdom of Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Professional Medical Expertise Company reported revenue of 419M SAR in FY2025 versus 131M SAR in FY2021, a compound +33.6%/yr. Reported net income was 41.7M SAR in FY2025, compounding +19.3%/yr from FY2021.
Is 9574 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $86.97 | $69.36 | -20% |
| Stryker Corporation SYK | $305.66 | $187.83 | -39% |
| Medtronic plc 2M6 | €64.08 | €37.00 | -42% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EWL | €74.64 | €31.98 | -57% |
| Siemens Healthineers AG SEMHF | $40.29 | $47.96 | +19% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
| STERIS plc S1TE34 | R$52.14 | R$8.02 | -85% |
| Zimmer Biomet Holdings Z1BH34 | R$119.88 | R$85.65 | -29% |
| Shanghai United Imaging Healthcare Co 688271 | ¥110.60 | ¥52.05 | -53% |
Compare Professional Medical Expertise Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Professional Medical Expertise Company (9574) overvalued or undervalued?
What is the fair value of 9574?
What is the quality score of 9574?
What is the revenue of Professional Medical Expertise Company (9574)?
What is the net profit margin of 9574?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Professional Medical Expertise Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.